Ljubljana, Slovenia

Peter Korošec


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Peter Korošec in Allergy Therapy

Introduction

Peter Korošec is an accomplished inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of allergy therapy through his innovative research and patents. His work focuses on developing solutions to combat allergic reactions caused by specific allergens.

Latest Patents

Peter Korošec holds a patent for "IgE epitope-like peptides and uses thereof." This invention relates to IgE epitope-like peptides that have the ability to bind to allergen-specific IgE paratopes. These allergen-specific IgEs are bound to effector cells of allergic patients. The IgE epitope-like peptides cover the paratopes of the IgE bound on effector cells, preventing the binding of the causative allergen. This mechanism helps to prevent degranulation and the secretion of mediators of allergic inflammation from effector cells upon contact with the allergen. The invention also outlines methods for using these peptides in the therapy of allergic reactions caused by exposure to allergens.

Career Highlights

Throughout his career, Peter Korošec has worked with notable institutions, including the University of Ljubljana and the University Clinic of Respiratory and Allergic Diseases. His research has focused on understanding and mitigating allergic responses, contributing to advancements in therapeutic approaches.

Collaborations

Peter has collaborated with esteemed colleagues such as Mojca Lunder and Borut Štrukelj. Their joint efforts have furthered research in the field of allergy and immunology, enhancing the understanding of allergic mechanisms and potential treatments.

Conclusion

Peter Korošec's innovative work in developing IgE epitope-like peptides represents a significant advancement in allergy therapy. His contributions have the potential to improve the quality of life for individuals suffering from allergic reactions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…